LDN for disease prevention and quality of life

[Guest guest]

http://www.ncbi.nlm.nih.gov/pubmed/19041189

The use of low-dose naltrexone (LDN) for the treatment and prophylaxis

of various bodily disorders is discussed. Accumulating evidence

suggests that LDN can promote health supporting immune-modulation

which may reduce various oncogenic and inflammatory autoimmune

processes. Since LDN can upregulate endogenous opioid activity, it may

also have a role in promoting stress resilience, exercise, social

bonding, and emotional well-being, as well as amelioration of

psychiatric problems such a autism and depression. It is proposed that

LDN can be used effectively as a buffer for a large variety of bodily

and mental ailments through its ability to beneficially modulate both

the immune system and the brain neurochemistries that regulate

positive affect.

[Guest guest]

this is a hypothesis

Sally

Zoe wrote:

>

> http://www.ncbi.nlm.nih.gov/pubmed/19041189

> <http://www.ncbi.nlm.nih.gov/pubmed/19041189>

>

> The use of low-dose naltrexone (LDN) for the treatment and prophylaxis

> of various bodily disorders is discussed. Accumulating evidence

> suggests that LDN can promote health supporting immune-modulation

> which may reduce various oncogenic and inflammatory autoimmune

> processes. Since LDN can upregulate endogenous opioid activity, it may

> also have a role in promoting stress resilience, exercise, social

> bonding, and emotional well-being, as well as amelioration of

> psychiatric problems such a autism and depression. It is proposed that

> LDN can be used effectively as a buffer for a large variety of bodily

> and mental ailments through its ability to beneficially modulate both

> the immune system and the brain neurochemistries that regulate

> positive affect.

>

>

> ------------------------------------------------------------------------

>

>

> No virus found in this incoming message.

> Checked by AVG - http://www.avg.com

> Version: 8.0.176 / Virus Database: 270.9.15/1838 - Release Date: 08/12/2008

18:16

>

>

[Guest guest]

I'm just passing on useful published information

Zoe

> >

> > http://www.ncbi.nlm.nih.gov/pubmed/19041189

> > <http://www.ncbi.nlm.nih.gov/pubmed/19041189>

> >

> > The use of low-dose naltrexone (LDN) for the treatment and

prophylaxis

> > of various bodily disorders is discussed. Accumulating evidence

> > suggests that LDN can promote health supporting immune-modulation

> > which may reduce various oncogenic and inflammatory autoimmune

> > processes. Since LDN can upregulate endogenous opioid activity,

it may

> > also have a role in promoting stress resilience, exercise, social

> > bonding, and emotional well-being, as well as amelioration of

> > psychiatric problems such a autism and depression. It is

proposed that

> > LDN can be used effectively as a buffer for a large variety of

bodily

> > and mental ailments through its ability to beneficially modulate

both

> > the immune system and the brain neurochemistries that regulate

> > positive affect.

> >

> >

> > -----------------------------------------------------------------

-------

> >

> >

> > No virus found in this incoming message.

> > Checked by AVG - http://www.avg.com

> > Version: 8.0.176 / Virus Database: 270.9.15/1838 - Release Date:

08/12/2008 18:16

> >

> >

>